Randomised, controlled trials are widely regarded as the gold standard by which the clinical effectiveness of healthcare products should be evaluated. Debate continues as to the value of this method of product assessment in a complex area such as wound care. Any method that is employed to define a product’s clinical value is, however, useless unless its ongoing effectiveness in a clinical area or with an individual patient is effectively monitored.